Mario Raviǵlione

Active 1989–2025

Also published as
Mario Raviglione
155
Papers
43,133
Citations
108
h-index
151
i10-index

Citations

Citations per year for Mario Raviǵlione1990: 2 citations1991: 1 citations1992: 9 citations1993: 11 citations1994: 16 citations1995: 42 citations1996: 45 citations1997: 68 citations1998: 133 citations1999: 131 citations2000: 141 citations2001: 196 citations2002: 202 citations2003: 233 citations2004: 264 citations2005: 286 citations2006: 291 citations2007: 325 citations2008: 298 citations2009: 316 citations2010: 295 citations2011: 298 citations2012: 334 citations2013: 263 citations2014: 356 citations2015: 268 citations2016: 296 citations2017: 241 citations2018: 252 citations2019: 926 citations2020: 898 citations2021: 821 citations2022: 542 citations2023: 353 citations2024: 560 citations2025: 228 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,449 citing papers, 17.4% of this breakdownUnited Kingdom: 1,270 citing papers, 9.1% of this breakdownIndia: 797 citing papers, 5.7% of this breakdownChina: 719 citing papers, 5.1% of this breakdownSouth Africa: 712 citing papers, 5.1% of this breakdownSwitzerland: 580 citing papers, 4.1% of this breakdownItaly: 441 citing papers, 3.1% of this breakdownFrance: 417 citing papers, 3% of this breakdownCanada: 411 citing papers, 2.9% of this breakdownNetherlands: 366 citing papers, 2.6% of this breakdownGermany: 345 citing papers, 2.5% of this breakdownAustralia: 341 citing papers, 2.4% of this breakdown
0%17.4%Other 37%

Fields

  • Medicine77.3%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Immunology and Microbiology4.7%
  • Health Professions1.6%
  • Economics, Econometrics and Finance1.5%
  • Chemistry1.3%
  • Other7%

Topics

  • Tuberculosis Research and Epidemiology23.6%
  • Mycobacterium research and diagnosis8%
  • Diagnosis and treatment of tuberculosis5.4%
  • Infectious Diseases and Tuberculosis5.1%
  • Pneumocystis jirovecii pneumonia detection and treatment4.2%
  • Pneumonia and Respiratory Infections2.9%
  • Other50.8%

Coauthors

All papers

Open in search
  1. Tuberculosis

    Authors: , , , , , , , , , , , - Nature Reviews Disease Primers 2016 cited by 1,239

  2. WHO's new End TB Strategy

    Authors: , , , , , , , , , , , , , , , - The Lancet 2015 cited by 1,027

  3. Latent Mycobacterium tuberculosis Infection

    Authors: , , , - New England Journal of Medicine 2015 cited by 778

  4. Drivers of tuberculosis epidemics: The role of risk factors and social determinants

    Authors: , , , , - Social Science & Medicine 2009 cited by 1,188

  5. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era

    Authors: , , , - The Lancet Respiratory Medicine 2018 cited by 448

  6. Tuberculosis control and elimination 2010–50: cure, care, and social development

    Authors: , , , , , , - The Lancet 2010 cited by 912

  7. Hospital-Acquired Infections in Critically Ill Patients With COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Foti, Roberto Fumagalli, Massimo Girardis, Marco Ranieri, Pierluigi Viale, Mario Raviǵlione, Antonio Pesenti, Andrea Gori, Alessandra Bandera - CHEST Journal 2021 cited by 399

  8. Building a tuberculosis-free world: The Lancet Commission on tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Soumya Swaminathan, Zelalem Temesgen, Anna Vassall, Nandita Venkatesan, Kitty Van Weezenbeek, Gavin Yamey, Bruce Agins, Sofia Alexandru, Jason R. Andrews, Naomi Beyeler, Stela Bivol, Grania Brigden, Adithya Cattamanchi, Danielle Cazabon, Valeriu Crudu, Amrita Daftary, Puneet Dewan, Laurie Doepel, Robert W. Eisinger, Victoria Y. Fan, Sara Fewer, Jennifer Furin, Jeremy D. Goldhaber‐Fiebert, Gabriela B. Gomez, Stephen M. Graham, Devesh Gupta, Maureen Kamene, Sunil Khaparde, Eunice Mailu, Enos Masini, Lorrie McHugh, Ellen M.H. Mitchell, Suerie Moon, Michael Osberg, Tripti Pande, Lea Prince, Kiran Rade, Raghuram Rao, Michelle Remme, James A. Seddon, Casey Selwyn, Priya B. Shete, Kuldeep Singh Sachdeva, Guy Stallworthy, Juan F Vesga, Valentina Vilc, Eric Goosby - The Lancet 2019 cited by 369

  9. Towards tuberculosis elimination: an action framework for low-incidence countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rosella Centis, Daniel Chemtob, Daniela María Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah Monica Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun‐Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O’Donnell, Analita Pace-Asciak, Maria Grazia Pompa, G Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Rühwald, J.P. Sculier, Aleksandar Šimunović, Alison Smith‐Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres‐Duque, Kazunori Umeki, Mukund Uplekar, Catharina Van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin, Mario Raviǵlione - European Respiratory Journal 2015 cited by 774

  10. Management of latentMycobacterium tuberculosisinfection: WHO guidelines for low tuberculosis burden countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Asker Ismayilov, Ernesto Jaramillo, Sandra V. Kik, Katharina Kranzer, Christian Lienhardt, Philip LoBue, Knut Lönnroth, Guy B. Marks, Dick Menzies, Giovanni Battista Migliori, Davide Mosca, Ya Diul Mukadi, Alwyn Mwinga, Lisa Nelson, Nobuyuki Nishikiori, Anouk Oordt-Speets, Molebogeng X. Rangaka, Andreas Reis, Lisa D. Rotz, Andreas Sandgren, Monica Sañé Schepisi, Holger J. Schünemann, Surender K. Sharma, Giovanni Sotgiu, Helen R. Stagg, Timothy R. Sterling, Tamara Tayeb, Mukund Uplekar, Marieke J. van der Werf, Wim Vandevelde, Femke van Kessel, Anna van't Hoog, Jay K. Varma, Natalia Vezhnina, Constantia Voniatis, Marije Vonk Noordegraaf‐Schouten, Diana Weil, Karin Weyer, Robert J. Wilkinson, Takashi Yoshiyama, J.-P. Zellweger, Mario Raviǵlione - European Respiratory Journal 2015 cited by 591

  11. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review

    Authors: , , , , - European Respiratory Journal 2014 cited by 586

  12. The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1

    Authors: , , , , , , , , - The Lancet Global Health 2018 cited by 180

  13. Zoonotic tuberculosis in human beings caused by Mycobacterium bovis—a call for action

    Authors: , , , , , , , , , , , , , - The Lancet Infectious Diseases 2016 cited by 371

  14. Tuberculosis

    Authors: , , , - New England Journal of Medicine 2013 cited by 697

  15. Prospects for Tuberculosis Elimination

    Authors: , , , - Annual Review of Public Health 2012 cited by 414

  16. Global Epidemiology of Tuberculosis

    Authors: , , - Seminars in Respiratory and Critical Care Medicine 2018 cited by 384

  17. The Growing Burden of Tuberculosis

    Authors: , , , , , , - Archives of Internal Medicine 2003 cited by 2,562

  18. The WHO policy package to combat antimicrobial resistance

    Authors: , , , - Bulletin of the World Health Organization 2011 cited by 319

  19. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

    Authors: , , - European Respiratory Review 2019 cited by 150

  20. Global Burden of Tuberculosis

    Authors: , , , , , - JAMA 1999 cited by 2,966

  21. Trends in tuberculosis incidence and their determinants in 134 countries

    Authors: , , , , - Bulletin of the World Health Organization 2009 cited by 374

  22. Tuberculosis 2015: Burden, Challenges and Strategy for Control and Elimination

    Authors: , - Infectious Disease Reports 2016 cited by 264

  23. Global Epidemiology of Tuberculosis

    Authors: , , , - Cold Spring Harbor Perspectives in Medicine 2014 cited by 255

  24. Digital health for the End TB Strategy: developing priority products and making them work

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2016 cited by 96